APA (7th ed.) Citation

Prashasti Agrawal, M., Michael Offin, M., Victoria Lai, M., Michelle S. Ginsberg, M., Prasad S. Adusumilli, M., Valerie W. Rusch, M., . . . Marjorie G. Zauderer, M. Combining a WT1 Vaccine (Galinpepimut-S) With Checkpoint Inhibition (Nivolumab) in Patients With WT1–Expressing Diffuse Pleural Mesothelioma: A Phase 1 Study. Elsevier.

Chicago Style (17th ed.) Citation

Prashasti Agrawal, MD, et al. Combining a WT1 Vaccine (Galinpepimut-S) With Checkpoint Inhibition (Nivolumab) in Patients With WT1–Expressing Diffuse Pleural Mesothelioma: A Phase 1 Study. Elsevier.

MLA (9th ed.) Citation

Prashasti Agrawal, MD, et al. Combining a WT1 Vaccine (Galinpepimut-S) With Checkpoint Inhibition (Nivolumab) in Patients With WT1–Expressing Diffuse Pleural Mesothelioma: A Phase 1 Study. Elsevier.